Dr. Hsiao-Chi Chuang is a leading expert in respiratory medicine and aerosol research, with a distinguished career in environmental lung disease, aerosol drug discovery, and pulmonary pathophysiology. He currently serves as a Professor at the School of Respiratory Therapy, Taipei Medical University, and President of the Taiwan Society for Aerosol in Medicine. His research focuses on the effects of aerosolized particles, air pollution, and therapeutic interventions on respiratory health, particularly in chronic lung diseases such as asthma and chronic obstructive pulmonary disease (COPD).
Dr. Chuang has published over 220 peer-reviewed articles in leading journals. His work has been widely cited, with an h-index of 40, reflecting his significant contributions to the field. His pioneering studies on particulate matter exposure, oxidative stress, lung microbiomes, and inflammation have provided crucial insights into novel aerosolized drug delivery systems for respiratory disease treatment.
Recognized among the World's Top 2% Scientists by Stanford University, Dr. Chuang has received multiple research and teaching excellence awards. He is also an editorial board member for prestigious journals such as the Journal of Hazardous Materials, contributing to global advancements in pulmonary medicine, air pollution research, and aerosol therapeutics.